Literature DB >> 16276407

B cells: no longer bystanders in liver fibrosis.

Rashpal K Bhogal1, Constantin A Bona.   

Abstract

Cytokines secreted by cells that mediate the innate and adaptive immune responses play a critical role in regulating the synthesis of ECM components by fibroblasts. Overexpression and deposition of ECM components are dominant features of fibrotic diseases, including hepatic fibrosis. The contribution of CD4+ Th2 cells to hepatic fibrosis has been well described. Now, in this issue of the JCI, Novobrantseva et al. provide data to suggest that hepatic B cells also play a role in liver injury (see the related article beginning on page 3072). In a carbon tetrachloride-induced mouse model of hepatic fibrosis, T cell-deficient mice developed severe liver fibrosis; however, in B cell-deficient animals, hepatic fibrosis was attenuated. This study provides new insight into our understanding of the cells involved in mediating the adaptive immune response that leads to hepatic fibrosis.

Entities:  

Mesh:

Year:  2005        PMID: 16276407      PMCID: PMC1265880          DOI: 10.1172/JCI26845

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

Review 1.  Factors involved in the regulation of type I collagen gene expression: implication in fibrosis.

Authors:  Asish K Ghosh
Journal:  Exp Biol Med (Maywood)       Date:  2002-05

2.  Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme.

Authors:  I Matsumoto; A Staub; C Benoist; D Mathis
Journal:  Science       Date:  1999-11-26       Impact factor: 47.728

3.  Attenuated liver fibrosis in the absence of B cells.

Authors:  Tatiana I Novobrantseva; Gerard R Majeau; Aldo Amatucci; Sophia Kogan; Ian Brenner; Stefano Casola; Mark J Shlomchik; Victor Koteliansky; Paula S Hochman; Alexander Ibraghimov
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

4.  Attenuated liver fibrosis and depressed serum albumin levels in carbon tetrachloride-treated IL-6-deficient mice.

Authors:  M Natsume; H Tsuji; A Harada; M Akiyama; T Yano; H Ishikura; I Nakanishi; K Matsushima; S Kaneko; N Mukaida
Journal:  J Leukoc Biol       Date:  1999-10       Impact factor: 4.962

5.  Scleroderma: increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture.

Authors:  J Uitto; E A Bauer; A Z Eisen
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

6.  Expression and cellular localization of fibrillin-1 in normal and pathological human liver.

Authors:  L Dubuisson; S Lepreux; P Bioulac-Sage; C Balabaud; A M Costa; J Rosenbaum; A Desmoulière
Journal:  J Hepatol       Date:  2001-04       Impact factor: 25.083

7.  Elevated interleukin-6 expression in keloid fibroblasts.

Authors:  H Xue; R L McCauley; W Zhang
Journal:  J Surg Res       Date:  2000-03       Impact factor: 2.192

Review 8.  Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.

Authors:  Shinichi Sato; Manabu Fujimoto; Minoru Hasegawa; Kazuhiko Takehara; Thomas F Tedder
Journal:  Mol Immunol       Date:  2004-11       Impact factor: 4.407

Review 9.  Role of profibrogenic cytokines secreted by T cells in fibrotic processes in scleroderma.

Authors:  Tracy L McGaha; Constantin A Bona
Journal:  Autoimmun Rev       Date:  2002-05       Impact factor: 9.754

10.  How can transforming growth factor beta be targeted usefully to combat liver fibrosis?

Authors:  Fanny W Shek; R Christopher Benyon
Journal:  Eur J Gastroenterol Hepatol       Date:  2004-02       Impact factor: 2.566

View more
  20 in total

1.  Lymphocytes contribute to biliary injury and fibrosis in experimental xenobiotic-induced cholestasis.

Authors:  Nikita Joshi; Anna K Kopec; Holly Cline-Fedewa; James P Luyendyk
Journal:  Toxicology       Date:  2016-12-31       Impact factor: 4.221

2.  Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation.

Authors:  Vijay Subramanian; Anil B Seetharam; Neeta Vachharajani; Venkataswarup Tiriveedhi; Nataraju Angaswamy; Sabarinathan Ramachandran; Jeffrey S Crippin; Surendra Shenoy; William C Chapman; Thalachallour Mohanakumar; Christopher D Anderson
Journal:  Transplantation       Date:  2011-12-15       Impact factor: 4.939

3.  Exenatide Prevents Diet-induced Hepatocellular Injury in A CEACAM1-Dependent Mechanism.

Authors:  Hilda E Ghadieh; Harrison T Muturi; Sonia M Najjar
Journal:  J Diabetes Treat       Date:  2017-12-19

4.  High-fat diet amplifies renal renin angiotensin system expression, blood pressure elevation, and renal dysfunction caused by Ceacam1 null deletion.

Authors:  Caixia Li; Silas A Culver; Syed Quadri; Kelly L Ledford; Qusai Y Al-Share; Hilda E Ghadieh; Sonia M Najjar; Helmy M Siragy
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-09-15       Impact factor: 4.310

5.  Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis.

Authors:  Lucia Russo; Hilda E Ghadieh; Simona S Ghanem; Qusai Y Al-Share; Zachary N Smiley; Cara Gatto-Weis; Emily L Esakov; Marcia F McInerney; Garrett Heinrich; Xin Tong; Lei Yin; Sonia M Najjar
Journal:  J Lipid Res       Date:  2016-10-24       Impact factor: 5.922

Review 6.  CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH).

Authors:  Sonia M Najjar; Lucia Russo
Journal:  Semin Immunopathol       Date:  2013-11-21       Impact factor: 9.623

7.  Immune response to extracellular matrix collagen in chronic hepatitis C-induced liver fibrosis.

Authors:  Brian B Borg; Anil Seetharam; Vijay Subramanian; Haseeb Ilias Basha; Mauricio Lisker-Melman; Kevin Korenblat; Christopher D Anderson; Surendra Shenoy; William C Chapman; Jeffrey S Crippin; Thalachallour Mohanakumar
Journal:  Liver Transpl       Date:  2011-07       Impact factor: 5.799

8.  Using immunoproteomics to identify alpha-enolase as an autoantigen in liver fibrosis.

Authors:  Bo Peng; Xueyong Huang; Ernesto S Nakayasu; John R Petersen; Suimin Qiu; Igor C Almeida; Jian-Ying Zhang
Journal:  J Proteome Res       Date:  2013-03-15       Impact factor: 4.466

9.  Insulin resistance dysregulates CYP7B1 leading to oxysterol accumulation: a pathway for NAFL to NASH transition.

Authors:  Genta Kakiyama; Dalila Marques; Rebecca Martin; Hajime Takei; Daniel Rodriguez-Agudo; Sandra A LaSalle; Taishi Hashiguchi; Xiaoying Liu; Richard Green; Sandra Erickson; Gregorio Gil; Michael Fuchs; Mitsuyoshi Suzuki; Tsuyoshi Murai; Hiroshi Nittono; Phillip B Hylemon; Huiping Zhou; William M Pandak
Journal:  J Lipid Res       Date:  2020-10-02       Impact factor: 5.922

Review 10.  Shared and distinct mechanisms of fibrosis.

Authors:  Jörg H W Distler; Andrea-Hermina Györfi; Meera Ramanujam; Michael L Whitfield; Melanie Königshoff; Robert Lafyatis
Journal:  Nat Rev Rheumatol       Date:  2019-11-11       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.